When paired with consistent lifestyle habits and monthly monitoring, GLP-1 medications can support steady, meaningful weight loss
Two other real-world studies found that patients treated with semaglutide showed average weight reductions ranging from 5.3 to 13.4% and improvements in cardiometabolic risk factors [20, 21]
These medications work by mimicking the action of naturally occurring incretin hormones, which stimulate insulin secretion in response to food intake, suppress glucagon release, slow gastric emptying, and promote satiety through central nervous system pathways
Five grams per day added over two weeks is much better tolerated than twenty grams added overnight
Accelerates blood flow and contributes to muscle strengthening
These attributes position GLP-1-T as a promising candidate for the treatment of metabolic conditions and underscore its potential to address multiple facets of metabolic health